Drugs / N11005
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04975022 | Dec 2019 → Aug 2020 | — | Beijing Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N11005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04975022 ↗ |
| Modality | Protein / enzyme biologic | “oral insulin N11005” NCT04975022 ↗ |